Estrella Immunopharma Inc
Yangkang Asset assisted Estrella Immunopharma (NASDAQ: ESLA) in successfully going public by spinning off from its parent company Eureka and completing a SPAC merger. The total capital raised from the listing and private placements amounted to approximately USD 44.3 million, including funds raised through PIPE private placements.
Estrella Immunopharma Inc Read More »